LOS ANGELES - TelAve -- A noninvasive technology could significantly benefit women diagnosed with breast cancer shares the American Association for Critical Illness Insurance.

One in eight U.S. women (about 12%) will develop invasive breast cancer over the course of her lifetime shares Jesse Slome, director of the American Association for Critical Illness Insurance.  "In 2020, an estimated 276,480 women will be diagnosed with invasive breast cancer. An additional 48,530 new cases of non-invasive (in situ) breast cancer will be diagnosed," Slome notes.

Researchers at Tel Aviv University announced development of a technique that improves gene delivery into breast cancer cells. The technique combines ultrasound with tumor-targeted microbubbles.

"Microbubbles are microscopic bubbles filled with gas," explains Dr. Tali Ilovitsh who led the research team.  This process increases the transfer of substances from the blood vessels into the surrounding tissue.  The researchers injected them directly into tumors in a mouse model.  About 80% of tumor cells were destroyed.

More on TelAve News

• Are You Hiring The Right Heater Repair Company in Philly?
• Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
• Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
• OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
• Indian Peaks Veterinary Hospital Launches Updated Dental Services Page for Boulder Pet Owners

The report in Proceedings of the National Academy of Sciences of the United States notes that membrane pores were formed in the remaining 20% of the cancer cells. This triggered an immune response that destroyed the cancer cells.

The critical illness insurance expert shared some data regarding breast cancer.  "For women under age 45 breast cancer is more common in Black women than white women," Slome explained.  Among Asian, Hispanic, and Native-American women, the risk of developing and dying from breast cancer is lower. Ashkenazi Jewish women have a higher risk of breast cancer because of a higher rate of BRCA mutations.

"Women must understand their real risk. In addition to examinations, planning is vital for the financial consequences associated with a breast cancer diagnosis," shares Slome.

Women will find their health insurance doesn't cover every dollar of costs. And taking off from their jobs to undergo treatments often means reduced income." A modest cancer insurance policy can cover healthcare costs," Slome advises. "Use it to replace lost income while you undergo treatment and recovery time. It's vital for women age 40 and older to consider."  For more information visit the association's website at https://www.criticalillnessinsuranceinfo.org or call 818-597-3205.

More on TelAve News

• Dugan Air Donates $10,000 to Indian Creek Schools
• Robert DeMaio, Phinge Founder & CEO, Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
• 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
• The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
• Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes

To read ways to find the best critical illness insurance, go to https://criticalillnessinsuranceinfo.org/best-critical-illness-insurance/.